Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized，Double-Blind, Multicenter，Placebo-Controlled, Parallel-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of HW091077 in Participants With Refractory Chronic Cough or Unexplained Chronic Cough (RCC/UCC).

NCT07483489 is registered in ClinicalTrials.gov with Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. as lead sponsor.

NCT NCT07483489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07483489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized，Double-Blind, Multicenter，Placebo-Controlled, Parallel-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of HW091077 in Participants With Refractory Chronic Cough or Unexplained Chronic Cough (RCC/UCC).
Lead sponsor
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
August 30, 2028
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

refractory chronic cough